| NDVAX | VISVX | NDVAX / VISVX | |
| Total Expense Ratio | 1.22 | 0.19 | 642% |
| Annual Report Gross Expense Ratio | 1.23 | 0.19 | 647% |
| Fund Existence | 15 years | 28 years | - |
| Gain YTD | 11.981 | 17.881 | 67% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.34B | 68.3B | 3% |
| Annual Yield % from dividends | 0.87 | 1.65 | 53% |
| Returns for 1 year | 7.83 | 23.48 | 33% |
| Returns for 3 years | 14.81 | 54.68 | 27% |
| Returns for 5 years | -5.98 | 50.65 | -12% |
| Returns for 10 years | 45.36 | 133.26 | 34% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MSSCX | 11.31 | 0.14 | +1.25% |
| AMG Frontier Small Cap Growth I | |||
| MINIX | 55.15 | 0.65 | +1.19% |
| MFS International Intrinsic Equity I | |||
| GSURX | 68.23 | 0.40 | +0.59% |
| Goldman Sachs US Equity Insights R | |||
| SGGAX | 84.67 | 0.41 | +0.49% |
| DWS Large Cap Focus Growth A | |||
| FRVEX | 43.34 | -0.06 | -0.14% |
| Fidelity Advisor Real Estate C | |||